The Phase II project of the Feiman Bio Changchun Jingyue Factory, undertaken by the Group Company, has officially commenced.
Release time:
2026-04-29
The Phase II project of the Feiman Bio Changchun Jingyue Factory, undertaken by the Group Company, has officially commenced construction.
On April 28, a grand groundbreaking ceremony was held for the Phase II project of the Feiman Bio Changchun Jingyue Factory, which is being constructed by the Group. Zhang Jian, General Manager of the company, Xu Bing, Deputy General Manager, and other senior executives attended the ceremony.
This project is being developed under an engineering, procurement, and construction (EPC) contracting model, with a planned gross floor area exceeding 20,000 square meters and a contract value of more than RMB 200 million. Construction is being undertaken by the Group’s Jinhui Branch. Leveraging Feiman Bio’s technological breakthroughs in the field of active collagen, the project will establish a full-industry-chain ecosystem spanning research and development to production, with the aim of setting a benchmark for the biopharmaceutical industry.
At the groundbreaking ceremony, General Manager Zhang Jian delivered a speech, stating that Jiangsu Qian’an will fully leverage its expertise in pharmaceutical infrastructure construction, honor its commitments through pragmatic action, and reciprocate the trust placed in it with uncompromising quality. Mr. Zhang urged the project team to spare no effort in creating greater value for the client, ensuring the project’s high-quality execution, and ushering in a new chapter of mutually beneficial cooperation between the two parties.
The successful commencement ceremony marks the entry of Jiangsu Qian’an’s collaboration with Feiman Biotechnology into a new phase, while also underscoring Jiangsu Qian’an’s professional expertise and technological strengths in the pharmaceutical infrastructure sector. Moving forward, the two parties will leverage this project as a strategic link to further deepen their cooperation, jointly driving innovation and development in the biopharmaceutical and medical aesthetics industries, and contributing to regional economic growth and industry advancement. (Jinhui Branch) 
Recommended news
2026-05-07
The Group Company Organizes the 2026 Spring Finance and Tax Training
On May 5, the Group Company organized a spring financial and tax training session in the conference room on the fourth floor of Qian’an Building, with the participation of more than 100 finance personnel from various branch companies and project departments.
2026-05-07
Group Labor Service Company Holds 2026 Annual Labor Management Work Conference
On April 30, the Group’s Labor Service Company convened the 2026 Annual Labor Management Work Conference in the 16th-floor conference room of Qian’an Building. All employees of the Labor Service Company, as well as labor administrators and team leaders from relevant branch companies, attended the meeting.
2026-04-29
On April 28, a grand groundbreaking ceremony was held for the Phase II project of the Feiman Bio Changchun Jingyue Factory, which is being constructed by our group company. Zhang Jian, General Manager of the company, Xu Bing, Deputy General Manager, and other senior executives attended the ceremony.
2026-04-28
In late April, the vehicle-based integrated energy service station project in the West Cargo Area of Shanghai Pudong International Airport, undertaken by the Group, successfully passed the handover inspection, and the hydrogen-fueling equipment has officially entered the installation phase.
2026-04-28
On April 28, the Third Enlarged Council Meeting of the Seventh Session of the Nantong Construction Industry Association was successfully held at the Nantong Jinshi International Hotel, with Cai Ting, Deputy General Manager of the Group Company, in attendance.
2026-04-27
On April 22, the 2025 Subcontractor Work Conference and Outstanding Subcontractor Recognition Ceremony of Sinopec Jiangsu Oil Construction Engineering Co., Ltd. was held in Yangzhou, with representatives from the Group attending.